| Literature DB >> 30526741 |
Kohei Uechi1,2, Tatsuya Tada3, Kyoko Kuwahara-Arai3, Jun-Ichiro Sekiguchi4, Izumi Yanagisawa4, Takaaki Tome2, Isamu Nakasone5, Shiro Maeda2, San Mya6, Khin Nyein Zan6, Htay Htay Tin6, Teruo Kirikae3, Jiro Fujita1.
Abstract
The modified carbapenem inactivation method (mCIM) is a simple phenotypic screening method for detecting carbapenemase production by Enterobacteriaceae and Pseudomonas aeruginosa. We recently developed another modified carbapenem inactivation method (CIMTris), in which carbapenemase is extracted from bacteria with Tris-HCl buffer, to detect carbapenemase production by Acinetobacter and Pseudomonas species. This study describes an improved carbapenem inactivation method, CIMTrisII, for detecting carbapenemase production by Gram-negative pathogens, including Enterobacteriaceae, Acinetobacter and Pseudomonas species. CIMTrisII was different from CIMTris in the concentration of Meropenem disks (5-µg MEM disks vs. 10-µg MEM disks), the inoculum volume of the bacteria (a 5-µl loopful vs. a 10 µl loopful) and the incubation time (1 vs. 2 h). CIMTrisII showed an overall sensitivity of 99.3 % and an overall specificity of 95.0 % for tested isolates. In comparison, CIMTris showed a sensitivity of 96.1 % and a specificity of 96.3 %, and mCIM showed a sensitivity of 67.1 % and a specificity of 100 %. CIMTrisII is thus deemed useful for detecting carbapenemase production by Gram-negative pathogens.Entities:
Keywords: Acinetobacter species; Carbapenem inactivation method; Carbapenem resistance; Carbapenemase; Enterobacteriaceae; Pseudomonas species
Mesh:
Substances:
Year: 2018 PMID: 30526741 DOI: 10.1099/jmm.0.000888
Source DB: PubMed Journal: J Med Microbiol ISSN: 0022-2615 Impact factor: 2.472